Isomorphism theorems of linear groups
2005
0 views
0 downloads
Advisor: Doç. Dr. Vladimir Tolstykh
Abstract (EN)
Genco FASThe goal in this thesis is the isomorphism theory of linear groups over fields as shownby the theoremTheorem: There is an isomorphism between any subset of the (projective) collineartransformations, (projective) general linear groups or (projective) special linear groups fordimension ⥠3 if and only if the dimensions of the finite dimensional vector spaces of thesesubspaces are equal and the underlying fields of these vector spaces are isomorphic.The theory that follows is typical of much of the research between the years 50?s and60?s on the isomorphisms of the classical groups over rings. The thesis will start from thebasic facts of calculus of residues and transvections. Then, in particular, the fundamentaltheorem of projective geometry will be proved and whatever is needed from projectivegeometry will be developed. Via reorganizing the literature on the isomorphisms of theclassical groups, it will be possible to extend the known theory from groups of lineartransformations to groups of collinear transformations, and also to improve the isomorphismtheory from dimension ⥠5 to dimension ⥠3.
Author
Genco Fas
How to Cite
Genco Fas (Master Thesis). Isomorphism theorems of linear groups, 2005, Yeditepe University.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)